# Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers

> **NCT04803708** · PHASE1,PHASE2 · COMPLETED · sponsor: **Technophage, SA** · enrollment: 20 (actual)

## Conditions studied

- Diabetic Foot Ulcer
- Pseudomonas Aeruginosa Infection
- Staphylococcus Aureus Infection
- Acinetobacter Infection

## Interventions

- **BIOLOGICAL:** TP-102

## Key facts

- **NCT ID:** NCT04803708
- **Lead sponsor:** Technophage, SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-22
- **Primary completion:** 2022-08-07
- **Final completion:** 2022-09-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04803708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04803708, "Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04803708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*